Healthy Aging

This randomized, double blind, placebo-controlled clinical study investigated the effectiveness of Bacopa monniera supplementation on memory performance in healthy older adults. Participants were randomized to receive a placebo or Bacopa, 300 mg per day for 12 weeks and assessed for neuropsychologic and subjective memory assessment at baseline and after 12 weeks of supplementation. Audioverbal and …

Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial   Read More »

The aim of this open label clinical study was to investigate the effectiveness of a standardized extract of Bacopa monnieri in improving the severity of ADHD symptoms. Children aged 6-12 years old, with an age of onset prior to 7 years of age were recruited for the study and received 225 mg bacopa extract daily …

An open-label study to elucidate the effects of standardized Bacopa monnieri extract in the management of symptoms of attention-deficit hyperactivity disorder in children   Read More »

This randomized, double blind, placebo-controlled trial planned to evaluate the effects of bacopa supplementation on cognitive function in healthy, elderly, study participants. Participants were randomized to receive a placebo or bacopa (300 mg/day) for 12 weeks, with a placebo run-in of 6 weeks. Each participant was assessed by the following measures: Rey Auditory Verbal Learning …

Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial  Read More »